Zydus Cadila’s Vaccine Gets Emergency Use nod form DCGI

Share This Post

Zydus Cadila’s three dose vaccine ZyCoV-D became sixth to get emergency use authorization from Drug Controller General of India (DCGA). It can be administered to anyone more than 12 years old.

ZyCoV-D is world’s first India’s indigenously developed DNA based needle-free vaccine for Covid-19.

Five others vaccines with emergency use approval are:

  1. Serum Institute’s Covishield
  2. Bharat Biotech’s Covaxin
  3. Russia’s Sputnik V,
  4. Moderna’s Vaccine
  5. Johnson and Johnson’s Vaccine

About ZyCoV-D

ZyCov-D is the world’s first DNA vaccine against infection with SARS-CoV-2. It is a “plasmid DNA” vaccine that uses a genetically engineered, non-replicating version of a type of DNA molecule known as a ‘plasmid’.

About Zydus Cadila

Cadila Healthcare is an Ahmedabad, Gujrat based multinational pharmaceutical company founded by Ramanbhai Patel in 1952. Zydus Pharmaceuticals (USA) Inc. is the US generic drug division of much larger company Zydus Cadila Healthcare. It has presence in more than 50 countries.

spot_img

Related Posts

Art and Literature of Middle Ages

Art during the Middle Ages was different based on...

Literature of Ancient India: Sanskrit Drama

The origin of Sanskrit drama is in obscurity; there...

The Bhakti Movement of the Medieval Age

The Bhakti Movement, one of the most remarkable features...

Saivism: Origin, Principles and Kinds

The origin of Saivism may be traced to, as...

Sikhism – An Introduction to Sikh Religion

Sikhism had its origin in the teachings of Guru...

The Gandhara Art

The Gandhara Art, justifying its name, is localized to...
- Advertisement -spot_img
Previous articleChina’s Three Child Policy
Next articleThe Vedic Age